Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study.
西地尼布单药治疗晚期肝细胞癌的疗效、安全性、药代动力学和生物标志物：一项 II 期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-12-3041
Zhu Andrew X, Ancukiewicz Marek, Supko Jeffrey G, Sahani Dushyant V, Blaszkowsky Lawrence S, Meyerhardt Jeffrey A, Abrams Thomas A, McCleary Nadine Jackson, Bhargava Pankaj, Muzikansky Alona, Sheehan Susan, Regan Eileen, Vasudev Eamala, Knowles Michelle, Fuchs Charles S, Ryan David P, Jain Rakesh K, Duda Dan G
